Trial · NCT02296931
Assessment of a Syringe Pump to Pre-eclamptic Women in a Low-resource Hospital
NCT02296931, Phase 1, Phase 2, Completed, William Marsh Rice University; results first posted 2016-10-05
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Assessment of a Syringe Pump to Pre-eclamptic Women in a Low-resource Hospital. Trials, record NCT02296931. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02296931
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Assessment of a Syringe Pump to Pre-eclamptic Women in a Low-resource Hospital
- NCT number
- NCT02296931
- Status
- Completed
- Phases
- Phase 1, Phase 2
- Enrollment
- 34 participants, actual
- Lead sponsor
- William Marsh Rice University
- Conditions
- Pre-eclampsia
- Interventions
- Saline, Magnesium Sulfate
- First posted
- 2014-11-21
- Last updated
- 2017-11-06
- Results first posted
- 2016-10-05
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Error in the Total Volume Dispensed and Flow Rate | 1 day visit | This is the error value for the volume dispensed by the AutoSyp device relative to the volume intended to be dispensed. Preeclamptic subjects received an initial loading dose followed by a maintenance dose. The loading dose had a flow rate of 60 mL/hr and delivered 20 mL in a single 20 mL syringe. The maintenance dose was 5 mL/hr and dispensed 120 mL total through two 60 mL syringes. The healthy subjects experienced variable flow rates and dispensed volumes, so they do not have the same variables as the pre-eclamptic pregnant women in the outcome data tables below. Because of these differences in dosing the two arms of the study, healthy women and preeclamptic women have different outcome measure data. |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Error in the Total Volume Dispensed and Flow Rate | 1 day visit | percentage of error | MEAN |
Source ClinicalTrials.gov
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Error in the Total Volume Dispensed and Flow Rate | Healthy Adults | Total Volume Dispensed-Loading Dose | NA | Full Range NA to NA | percentage of error |
| Error in the Total Volume Dispensed and Flow Rate | Pre-eclamptic Pregnant Women | Total Volume Dispensed-Loading Dose | -1.48 | Full Range -2.58 to -0.58 | percentage of error |
| Error in the Total Volume Dispensed and Flow Rate | Healthy Adults | Flow Rate-Loading Dose | NA | Full Range NA to NA | percentage of error |
| Error in the Total Volume Dispensed and Flow Rate | Pre-eclamptic Pregnant Women | Flow Rate-Loading Dose | -1.75 | Full Range -2.53 to -1.47 | percentage of error |
| Error in the Total Volume Dispensed and Flow Rate | Healthy Adults | Total Volume Dispensed-Maintenance Dose | NA | Full Range NA to NA | percentage of error |
| Error in the Total Volume Dispensed and Flow Rate | Pre-eclamptic Pregnant Women | Total Volume Dispensed-Maintenance Dose | -1.13 | Full Range -2.28 to -0.41 | percentage of error |
| Error in the Total Volume Dispensed and Flow Rate | Healthy Adults | Flow Rate-Maintenance Dose | NA | Full Range NA to NA | percentage of error |
| Error in the Total Volume Dispensed and Flow Rate | Pre-eclamptic Pregnant Women | Flow Rate-Maintenance Dose | -1.11 | Full Range -2.09 to -0.76 | percentage of error |
| Error in the Total Volume Dispensed and Flow Rate | Healthy Adults | Flow Rate-Variable | -0.21 | Full Range -2.90 to 4.95 | percentage of error |
| Error in the Total Volume Dispensed and Flow Rate | Pre-eclamptic Pregnant Women | Flow Rate-Variable | NA | Full Range NA to NA | percentage of error |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 results by groupParticipant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Healthy Adults | 10 | |
| Overall Study | STARTED | Pre-eclamptic Pregnant Women | 24 | |
| Overall Study | COMPLETED | Healthy Adults | 10 | |
| Overall Study | COMPLETED | Pre-eclamptic Pregnant Women | 22 | |
| Overall Study | NOT COMPLETED | Healthy Adults | 0 | |
| Overall Study | NOT COMPLETED | Pre-eclamptic Pregnant Women | 2 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Healthy Adults | ||
| Total, all-cause mortality | Pre-eclamptic Pregnant Women | ||
| Total, other adverse events | Healthy Adults | 0 | 10 |
| Total, other adverse events | Pre-eclamptic Pregnant Women | 0 | 24 |
| Total, serious adverse events | Healthy Adults | 0 | 10 |
| Total, serious adverse events | Pre-eclamptic Pregnant Women | 0 | 24 |
Source ClinicalTrials.gov
Papers3
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons1
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison |
|---|
| Healthy Adults vs Pre-eclamptic Pregnant Women: serious adverse events |
Source Trial comparisons
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02296931
GET https://conductscience.org/api/trials/v1/NCT02296931/registered